Ethan Shields
FDA Clears Zepbound as New Treatment Option for Obesity and Overweight with Weight-Related Conditions
FDA Approves Tirzepatide (Zepbound) for Chronic Weight Management
Read More →Why Is Healthy Living Important for Students?
Students who prioritize healthy living sharpen their focus, build emotional resilience, and create habits that support…
Read More →FDA Warns Consumers About Undeclared Ingredients in Over-The-Counter Male Sexual Enhancement Products
The U.S. Food and Drug Administration has identified numerous male sexual enhancement supplements that carry…
Read More →What Does a Healthy Diet Look Like?
A healthy diet is a sustainable pattern of eating built on variety, whole foods, balance, and pleasure that nourishes…
Read More →FDA Clarifies Predetermined Change Control Plans for AI-Driven Clinical Decision Support Tools
FDA Updates Details on Predetermined Change Control Plans for AI/ML Software as Medical Device
Read More →FDA Clears Zepbound as New Option for Obesity Treatment
FDA Approves Zepbound (Tirzepatide) for Chronic Weight Management
Read More →FDA Clears First OTC CGM Device for Diabetes Management and Prevention
FDA Clears First Over-the-Counter Continuous Glucose Monitor
Read More →FDA Identifies Undeclared PDE5 Inhibitors in Over-The-Counter Products Marketed for Sexual Enhancement
FDA Documents Hidden PDE-5 Inhibitors in Dozens of Male Enhancement Supplements
Read More →Pooled Cohort Data Link Consistent Wearable Use to Modest Improvements in Blood Pressure and Lipid Profiles Among Men Aged 40–65
Evidence from a randomized clinical trial and large cohort assessments links wearable activity trackers to increases…
Read More →FDA Authorizes Updated mRNA COVID-19 Vaccines Targeting KP.2 Variant for 2024-2025 Season
FDA Authorizes Updated Monovalent COVID-19 Vaccines Targeting KP.2 for 2024-2025 Season
Read More →FDA and CDC Clear Reformulated mRNA COVID-19 Vaccines for Fall 2024 Use
FDA Authorizes Updated 2024-2025 COVID-19 Vaccines Targeting KP.2 Lineage
Read More →Shorter Sleep Duration Consistently Linked to Lower Testosterone in Multiple Cohort Analyses
Observational Evidence Shows Association Between Shorter Sleep, Poor Sleep Quality, and Lower Testosterone in Adult Men
Read More →FDA Warns Consumers About Hidden PDE5 Inhibitors in Over-The-Counter Male Enhancement Products
The U.S. Food and Drug Administration has identified multiple male sexual enhancement supplements that contain…
Read More →Sleep and Testosterone: Answering Reader Questions from CDC and NIH Primary Reports
CDC and NIH sources state that adults need 7 or more hours of sleep per night. NIH materials link sleep restriction…
Read More →FDA Clarifies Regulatory Expectations for AI Tools in Heart Disease Prevention
FDA Issues Draft Guidance on AI/ML Software for Cardiovascular Risk Assessment
Read More →FDA Clarifies Regulatory Expectations for Software Monitoring Cardiovascular and Metabolic Parameters in Men
FDA Clarifies Regulatory Expectations for Digital Health Technologies in Remote Physiologic Monitoring
Read More →FDA Clarifies Oversight of Software and Devices Marketed for Digital Wellness Tracking
FDA Guidance Excludes Low-Risk Wellness Technologies From Medical Device Regulation
Read More →CDC Issues Shared Clinical Decision-Making Guidance for RSV Vaccines in Older Adults
CDC Updates RSV Vaccine Recommendations for Adults Aged 60 and Older
Read More →FDA Warns of Hidden Ingredients in Online Erectile Dysfunction Products
FDA Updates Tracking of Tainted Sexual Enhancement Products Containing Undeclared PDE5 Inhibitors
Read More →FDA Warns of Hidden PDE5 Inhibitors and Anabolic Steroids in Over-The-Counter Male Supplements
FDA Warns of Hidden PDE5 Inhibitors and Anabolic Steroids in Over-the-Counter Male Supplements
Read More →FDA Warns of Undeclared PDE5 Inhibitors in OTC Male Enhancement Products
FDA Warns of Undeclared PDE5 Inhibitors in OTC Male Enhancement Products
Read More →FDA Mandates Revised Cardiovascular and Prostate Cancer Risk Information in Testosterone Therapy Labeling
FDA Requires Updated Safety Labeling for Testosterone Replacement Therapy Products
Read More →FDA Highlights Post-Approval Cardiovascular and Gastrointestinal Data for Semaglutide
FDA Highlights Post-Approval Cardiovascular and Gastrointestinal Data for Semaglutide
Read More →FDA Detects Hidden Prescription Ingredients in Over-The-Counter Male Sexual Enhancement Products
FDA Detects Hidden Prescription Ingredients in Over-the-Counter Male Sexual Enhancement Products
Read More →FDA Warns Consumers of Hidden Sildenafil and Tadalafil in Over-The-Counter Male Sexual Enhancement Products
FDA Warns Consumers of Hidden Sildenafil and Tadalafil in Over-the-Counter Male Sexual Enhancement Products
Read More →FDA Clarifies Regulatory Expectations for AI-Powered Digital Health Tools
FDA Clarifies Regulatory Expectations for AI-Powered Digital Health Tools
Read More →FDA Outlines Regulatory Expectations for AI Tools Used in Heart Disease Prediction
FDA Outlines Regulatory Expectations for AI Tools Used in Heart Disease Prediction
Read More →FDA Clarifies Evidence Standards for Digital Tools Used in Remote Monitoring and Preventive Health
FDA Clarifies Evidence Standards for Digital Tools Used in Remote Monitoring and Preventive Health
Read More →FDA Proposes New Framework for Regulating AI in Consumer Digital Health Tools
FDA Proposes New Framework for Regulating AI in Consumer Digital Health Tools
Read More →